Hologic (HOLX) EBITDA (2008 - 2025)
Hologic (HOLX) EBITDA from Jun 28, 2008 to Dec 27, 2025. The TTM Hologic (HOLX) EBITDA is $715M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Hologic (HOLX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4.91% |
| 3 Years TTM | -0.64% |
| 5 Years TTM | -12.55% |
| 10 Years TTM | +5.65% |
Annual EBITDA change of Hologic (HOLX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $823M | -16.16% |
| 2024 | $982M | +29.54% |
| 2023 | $758M | -56.17% |
| 2022 | $1.73B | -32.66% |
| 2021 | $2.57B | +116.17% |
| 2020 | $1.19B | -3895.85% |
| 2019 | -$31M | -131.74% |
| 2018 | $99M | -86.60% |
| 2017 | $736M | +16.64% |
| 2016 | $631M | +643.11% |
| 2015 | $85M | +190.75% |
| 2014 | $29M | -103.60% |
| 2013 | -$811M | -26251.61% |
| 2012 | $3.10M | -85.10% |
| 2011 | $21M | -84.96% |
| 2010 | $138M | +430.27% |
| 2009 | $26M | -117.98% |
| 2008 | -$145M | -189.56% |
| 2007 | $162M | N/A |
Comparison Hologic (HOLX) five years EBITDA CAGR with competitors
Hologic (HOLX) five years EBITDA CAGR is -16.35%.